Haehnel, Patricia S.; Enders, Birgit; Sasca, Daniel et al.
Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapyBLOOD. Bd. 123. H. 15. 2014 S. 2355-2366
Nikolova, Teodora; Dvorak, Mirek; Jung, Fabian et al.
The gamma H2AX Assay for Genotoxic and Nongenotoxic Agents: Comparison of H2AX Phosphorylation with Cell Death ResponseTOXICOLOGICAL SCIENCES. Bd. 140. H. 1. 2014 S. 103-117
Tomicic, Maja T.; Aasland, Dorthe; Naumann, Steffen C. et al.
Translesion Polymerase eta Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug ResistanceCANCER RESEARCH. Bd. 74. H. 19. 2014 S. 5585-5596
Fahrer, Joerg; Rausch, Johannes; Barth, Holger
A Cell-Permeable Fusion Protein Based on Clostridium botulinum C2 Toxin for Delivery of p53 Tumorsuppressor into Cancer CellsPLOS ONE. Bd. 8. H. 9. 2013
Faust, Dagmar; Vondracek, Jan; Krcmar, Pavel et al.
AhR-mediated changes in global gene expression in rat liver progenitor cellsARCHIVES OF TOXICOLOGY. Bd. 87. H. 4. 2013 S. 681-698
Faust, Dagmar; Kletting, Stephanie; Ueberham, Elke et al.
Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cellsTOXICOLOGY LETTERS. Bd. 223. H. 1. 2013 S. 73-80
Fahrer, Joerg; Schweitzer, Brigitte; Fiedler, Katja et al.
C2-Streptavidin Mediates the Delivery of Biotin-Conjugated Tumor Suppressor Protein P53 into Tumor CellsBIOCONJUGATE CHEMISTRY. Bd. 24. H. 4. 2013 S. 595-603
Hristova, Rositsa; Hadjidekova, Valeria; Grigorova, Mira et al.
Chromosome analysis of nuclear power plant workers using fluorescence in situ hybridization and Giemsa assayJOURNAL OF RADIATION RESEARCH. Bd. 54. H. 5. 2013 S. 832-839
Korfei, Martina; von der Beck, Daniel; Henneke, Ingrid et al.
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donorsJOURNAL OF PROTEOMICS. Bd. 85. 2013 S. 109-128
Eich, Marcus; Roos, Wynand Paul; Nikolova, Teodora et al.
Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug TemozolomideMOLECULAR CANCER THERAPEUTICS. Bd. 12. H. 11. 2013 S. 2529-2540